BioWorld

June 27, 2002

Serono To Buy Out Genset Through EUR107.4M Cash Offer

The world found out Wednesday who's been wooing Paris-based Genset SA, and it turned out to be Serono SA, which made a cash offer to buy Genset for €107.4 million. (BioWorld Today) Read More

Neuronyx, J&J's Centocor Sign Adult Stem Cell Collaboration

Interacting Ribonucleic Acid Plus Little-Known Dicer Enzyme Knock Down HIV, With Therapeutic Intent

Scynexis, Merck To Collaborate On Anti-Infective Compounds

Other News To Note

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for Dec. 10, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 10, 2025.

Medline plans record-setting $5.37B IPO

BioWorld MedTech

Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...

US lawmakers demand that Kennedy be held accountable

BioWorld

As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...

Heartbeam wins appeal, gains FDA clearance

BioWorld MedTech

Management is beaming with delight at Heartbeam Inc. as the company's appeal strategy paid off with U.S. FDA clearance for its synthetic 12-lead electrocardiogram...